Literature DB >> 21440870

Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.

Dan D Matlock1, Jean S Kutner, Caroline B Emsermann, Sana M Al-Khatib, Gillian D Sanders, L Miriam Dickinson, John S Rumsfeld, Arthur J Davidson, Lori A Crane, Frederick A Masoudi.   

Abstract

INTRODUCTION: This study was designed to determine if physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators (ICDs) are regionally associated with ICD use. METHODS AND
RESULTS: A national sample of 9969 members of the American College of Cardiology was surveyed electronically. Responses were merged with rates of ICD implantation from the National Cardiovascular Data Registry. Multivariable regression was used to assess trends between regional use and responses. We received 1210 responses (12%) and used 1124 after exclusions. Across regions, physicians were equally likely to recommend ICDs to males or females with ischemic (∼99% for both; P = NS) or nonischemic cardiomyopathy (85 vs. 88% P = 0.85). Significant increasing trends in the probability recommending ICD therapy were found when the patient was "frail" (21% to 32%; P = .03) or had a life expectancy <1 year (5% to 10%; P = .05). These differences were not associated with attitudes toward ICDs.
CONCLUSIONS: Independent of variations in physicians' attitudes towards ICDs, physicians in regions of low ICD use are not less likely to recommend ICDs in situations clearly supported by guidelines while those in regions of high ICD use are more likely to recommend ICDs to patients who might have limited benefit.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21440870     DOI: 10.1016/j.cardfail.2010.11.009

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  6 in total

1.  Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.

Authors:  Jorge M Castellanos; Lisa M Smith; Paul D Varosy; Christine Dehlendorf; Gregory M Marcus
Journal:  Heart Rhythm       Date:  2012-02-02       Impact factor: 6.343

2.  Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.

Authors:  Dan D Matlock; Pamela N Peterson; Yongfei Wang; Jeptha P Curtis; Matthew R Reynolds; Paul D Varosy; Frederick A Masoudi
Journal:  Arch Intern Med       Date:  2012-04-23

Review 3.  The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis.

Authors:  Attila Roka; Mark H Schoenfeld
Journal:  J Interv Card Electrophysiol       Date:  2012-12-15       Impact factor: 1.900

Review 4.  The biologic syndrome of frailty in heart failure.

Authors:  Rita Jermyn; Snehal Patel
Journal:  Clin Med Insights Cardiol       Date:  2015-03-02

5.  Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study.

Authors:  Raymond N Kuo; Chao-Lun Lai; Yi-Chun Yeh; Mei-Shu Lai
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

6.  Admissions to intensive cardiac care units in France in 2014: A cross-sectional, nationwide population-based study.

Authors:  Grégoire Mercier; Claire Duflos; Adeline Riondel; Clément Delmas; Stéphane Manzo-Silberman; Guillaume Leurent; Meyer Elbaz; Eric Bonnefoy-Cudraz; Patrick Henry; François Roubille
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.